Teleflex Stock Price - TFX

-13.09 (-3.41%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Teleflex Inc TFX NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-13.09 -3.41% 371.27 365.75 384.94 382.82 384.36 12:39:13
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,553 130,982 $ 376.07 $ 49,258,964 171,677 269.88 - 398.65
Last Trade Time Type Quantity Stock Price Currency
12:39:08 1 $ 371.04 USD

Teleflex Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 17.29B 46.30M $ 200.80M 4.29 40.50 45.22M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
606.16k $ 1.36 0.36% 11/14/19 12.00 2.30%

more financials information »

Teleflex News

Loading Messages....

Latest TFX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TFX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week382.06398.65365.75388.55243,655-10.79-2.82%
1 Month385.29398.65365.75381.47179,289-14.02-3.64%
3 Months351.74398.65346.83374.03187,17519.535.55%
6 Months370.21398.65311.64352.46230,6981.060.29%
1 Year270.94398.65269.88332.01241,162100.3337.03%
3 Years180.21398.65178.60271.68264,125191.06106.02%
5 Years121.20398.65117.96219.67270,430250.07206.33%

Teleflex Description

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the vascular access and surgical areas. The firm reports in eight primary segments: vascular North America (13% of 2018 sales), interventional North America (11%), anesthesia North America (8%), surgical North America (7%), Europe, Middle East, Africa (25%), Asia (12%), original-equipment manufacturing (8%), and all other (16%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.